Skip to main content
. Author manuscript; available in PMC: 2021 Jul 16.
Published in final edited form as: Am J Gastroenterol. 2018 Feb 20;113(6):899–905. doi: 10.1038/s41395-018-0007-x

Table 2.

Adjusted odds ratios (95% confidence intervals) for any metachronous CRA or advanced metachronous CRA compared to no CRA according to CRC family history characteristics

Any metachronous adenoma
Advanced metachronous adenoma
Family history characteristic CRA/total Adjusted OR (95% CI)a CRA/total Adjusted OR (95% CI)a
No family history 2777/5818 1.00 (Referent) 710/5818 1.00 (Referent)
Any first-degree relative 942/1879 1.14 (1.01–1.29) 239/1879 1.15 (0.96–1.37)
Specific relativeb
 Mother 318/616 1.27 (1.05–1.53) 74/616 1.24 (0.94–1.65)
 Father 275/613 0.91 (0.75–1.10) 65/613 0.92 (0.69–1.24)
 Sibling 360/643 1.34 (1.11–1.62) 96/643 1.24 (0.95–1.62)
Number of relativesb
 1 655/1357 1.07 (0.93–1.23) 167/1357 1.14 (0.93–1.40)
 2+ 117/212 1.39 (1.02–1.91) 29/212 1.32 (0.83–2.07)
p-trend 0.05 0.11
Youngest age of sibling CRC diagnosis
 <54 years 65/107 1.66 (1.08–2.56) 15/107 1.24 (0.66–2.33)
 55–64 years 66/116 1.34 (0.89–2.03) 14/116 0.99 (0.53–1.85)
 >65 years 49/97 1.10 (0.70–1.72) 11/97 0.71 (0.35–1.43)
p-trend 0.008 0.79
a

Models adjusted for age, sex, history of polyps prior to baseline, number of colonoscopies during follow-up; and baseline adenoma location (distal, proximal, both) and baseline adenoma size

b

Data are missing or could not be definitively ascertained for specific relative (n = 7) and number of relatives (n = 310)